Literature DB >> 7810664

Interleukin-1 beta inhibits gastric histamine secretion and synthesis in the rat.

S Kondo1, Y Shinomura, S Kanayama, S Kawabata, Y Miyazaki, I Imamura, H Fukui, Y Matsuzawa.   

Abstract

Interleukin-1 beta (IL-1 beta) is the most potent inhibitor of gastric acid secretion known at present. Although histamine has been shown to be an important mediator of gastric acid secretion, the effect of IL-1 beta on gastric histamine mobilization has not been studied. In the present study, the effects of IL-1 beta on gastric acid secretion and gastric histamine mobilization were investigated in conscious rats with both gastric and vesical fistulas. IL-1 beta (5 micrograms/kg iv) significantly inhibited basal acid secretion but did not affect basal urinary histamine excretion and fundic histidine decarboxylase (HDC) activity. Gastrin-17-I (1 nmol.kg-1.h-1) caused a marked increase in acid secretion, urinary histamine secretion, and fundic HDC activity. IL-1 beta (5 micrograms/kg iv) completely inhibited gastrin-induced acid secretion and partially inhibited urinary histamine excretion and fundic HDC activity. Pretreatment with indomethacin (10 mg/kg ip) partially reversed the inhibitory effects of IL-1 beta on gastrin-stimulated fundic HDC activity and acid secretion. These findings indicate that IL-1 beta inhibits gastric histamine mobilization through both prostaglandin-dependent and prostaglandin-independent pathways. Furthermore, it is suggested that the inhibitory action of IL-1 beta on gastric acid secretion is mediated by the inhibition of gastric histamine mobilization.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7810664     DOI: 10.1152/ajpgi.1994.267.6.G966

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  17 in total

1.  Effects of Helicobacter pylori infection on gastric acid secretion and serum gastrin levels in Mongolian gerbils.

Authors:  M Takashima; T Furuta; H Hanai; H Sugimura; E Kaneko
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

2.  Effect of Th1 cytokines on acid secretion in pharmacologically characterised mouse gastric glands.

Authors:  I T Padol; R H Hunt
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

3.  Interleukin-4 receptor -3223T→C polymorphism is associated with increased gastric adenocarcinoma risk.

Authors:  Florin Burada; Cristina Angelescu; Paul Mitrut; Tudorel Ciurea; Mihai Cruce; Adrian Saftoiu; Mihai Ioana
Journal:  Can J Gastroenterol       Date:  2012-08       Impact factor: 3.522

4.  Diverse H. pylori strains, IL-10 promoter polymorphisms with high morbidity of gastric cancer in Hexi area of Gansu Province, China.

Authors:  Xiangting Zeng; Yumin Li; Tao Liu; Junqiang Zhang
Journal:  Mol Cell Biochem       Date:  2011-11-13       Impact factor: 3.396

5.  Effect of N alpha-methyl-histamine on acid secretion in isolated cultured rabbit parietal cells: implications for Helicobacter pylori associated gastritis and gastric physiology.

Authors:  I L Beales; J Calam
Journal:  Gut       Date:  1997-01       Impact factor: 23.059

6.  Relation between clinical presentation, Helicobacter pylori density, interleukin 1beta and 8 production, and cagA status.

Authors:  Y Yamaoka; T Kodama; M Kita; J Imanishi; K Kashima; D Y Graham
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

7.  Interleukin 1B proinflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy.

Authors:  T Ando; E M El-Omar; Y Goto; K Nobata; O Watanabe; O Maeda; K Ishiguro; M Minami; N Hamajima; H Goto
Journal:  Gut       Date:  2005-08-24       Impact factor: 23.059

8.  Gastric acid normosecretion is not essential in the pathogenesis of mild erosive gastroesophageal reflux disease in relation to Helicobacter pylori status.

Authors:  Tomohiko Shimatani; Masaki Inoue; Nobue Harada; Yoko Horikawa; Masuo Nakamura; Susumu Tazuma
Journal:  Dig Dis Sci       Date:  2004-05       Impact factor: 3.199

Review 9.  Virulence factor genotypes of Helicobacter pylori affect cure rates of eradication therapy.

Authors:  Mitsushige Sugimoto; Yoshio Yamaoka
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2009-02-14       Impact factor: 4.291

10.  Helicobacter pylori induces in-vivo expansion of human regulatory T cells through stimulating interleukin-1β production by dendritic cells.

Authors:  P J Mitchell; B Afzali; H Fazekasova; D Chen; N Ali; N Powell; G M Lord; R I Lechler; G Lombardi
Journal:  Clin Exp Immunol       Date:  2012-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.